The only published report for DAXX protein expression in chronic lymphocytic leukemia (CLL) can be found in the study of Bojarska-Junak et al., where the authors documented a positive correlation between the expression of prostate apoptosis response-4 (Par-4) protein and DAXX protein, assessed via flow cytometry in peripheral blood and BM samples from patients with untreated CLL [99]. This evidence concerns the gene DAXX and B-cell chronic lymphocytic leukemia.